Chemical & Engineering NewsNovartis to buy Avexis in $8.7 billion gene-therapy dealSFGateNovartis has agreed to acquire Avexis for $8.7 billion to gain a promising drug to treat a rare disease that afflicts infants, hastening a shift toward gene therap… Continue reading
New York Times |
New & Noteworthy
New York Times … DANCES By Guido Maria Brera and Edoardo Nesi. Translated by Antony Shugaar. (Other, $18.95.) Nesi and Brera rail against globalization and its deleterious effects on a country like Italy. Nesi, who had to close his grandfather’s decades-old textile … |
Forbes |
Just How Smart Is Smart Medicine? MIT Scientists Are About To Find Out
Forbes We have smart phones, smart cars and now, with the advent of a new class of “living medicines,” we’re on the verge of having smart therapeutics. Synlogic, a Cambridge, Massachusetts-based MIT spin-out, is applying engineering principles to biology to … |
Life Sciences Intellectual Property Review |
How These Gene Therapy Stocks Benefit From Novartis-AveXis Deal
Investor’s Business Daily The implications of Novartis’ deal for Spark are less clear. Spark is already partnered with Novartis on gene therapy Luxturna in Europe. Investors had been optimistic about the potential for a merger between Novartis and Spark. “We think investor … Novartis to buy Avexis in $8.7 billion gene–therapy dealSFGate Novartis signs $8.7bn gene therapy dealLife Sciences Intellectual Property Review Novartis increases presence in gene therapy with AveXis acquisitionEPM Magazine MENAFN.COM all 45 news articles » |
Life Sciences Intellectual Property Review |
How These Gene Therapy Stocks Benefit From Novartis-AveXis Deal
Investor’s Business Daily The implications of Novartis’ deal for Spark are less clear. Spark is already partnered with Novartis on gene therapy Luxturna in Europe. Investors had been optimistic about the potential for a merger between Novartis and Spark. “We think investor … Novartis to buy Avexis in $8.7 billion gene–therapy dealSFGate Novartis signs $8.7bn gene therapy dealLife Sciences Intellectual Property Review Novartis increases presence in gene therapy with AveXis acquisitionEPM Magazine MENAFN.COM all 45 news articles » |
The Daily Gazette |
Medical breakthrough: Seattle man is first adult to get new gene therapy for vision
Medical Xpress So Willis checked in with his eye doctor late last year, setting in motion a train of events that culminated March 20 at Children’s Hospital Los Angeles (CHLA) when he became the first adult to undergo the first gene therapy approved in the U.S. for … Seattle man is first adult to get new gene therapy for vision | The …The Daily Gazette Gene Therapy Prevents Vision Loss Caused by CLN6 Disease in Mouse StudyBatten Disease News Otsuka and Takara team up to develop gene therapy candidates in oncologyThe Pharma Letter Medgadget (blog) –Business Services –Healthcare Journal all 12 news articles » |